MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Clinical trial NCT01310244 · COMPLETED

Trial details

NCT number: NCT01310244
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Non-small Cell Lung Cancer

Start date: 2010-12-01
Primary completion: 2015-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.